Ketoconazole 2% foam for treatment of seborrheic dermatitis

References

• Gupta AK, Mphil RB, Bluhm R, Boekhout T, Dawson TL. Skin diseases associated with Malassezia species. J. Am. Acad. Dermatol.51(5), 785–798 (2004).
   PubMed Web of Science ®Google Scholar
• Altmeyer P, Hoffman K. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial. Int. Soc. Dermatol.43(Suppl. 1), 9–12 (2004).
   PubMedGoogle Scholar
• Dreno B, Chosidow O, Revuz J, Moyse D. Lithium gluconate 8% vs. ketoconazole 2 % in the treatment of seborrheic dermatitis: a multicentre, randomized study. Br. J. Dermatol.148 (6), 1230–1236 (2003).
   PubMed Web of Science ®Google Scholar
• Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrheic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br. J. Dermatol.132(3), 441–445 (1995).
   PubMed Web of Science ®Google Scholar
• DeAngelis YM, Gemmer CM, Kaczvinscky JR, Kenneally DC, Schwartz JR, Dawson TL. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J. Investig. Dermatol. Symp. Proc.10(3), 295–297 (2005).
   PubMedGoogle Scholar
• Gupta AK, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am. J. Clin. Dermatol.5(6), 417–422 (2004).
   PubMed Web of Science ®Google Scholar
• Gueho E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek69(4), 337–355 (1996).
   PubMed Web of Science ®Google Scholar
• Sugita T, Suto H, Unno T et al. Molecular analysis of malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J. Clin. Microbiol.39(10), 3486–3490 (2001).
   PubMed Web of Science ®Google Scholar
• Ro BI, Dawson TL. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J. Investig. Dermatol. Symp. Proc.10(3), 194–197 (2005).
   Google Scholar
• Draeolos ZD, Keneally DC, Hodges LT, Billhimer W, Copas M, Margraf C. A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos. J. Investig. Dermatol. Symp. Proc.10(3), 201–204 (2005).
   Google Scholar
• Gupta AK, Nicol KA. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis. Int. J. Dermatol.45(1), 66–69 (2006).
   PubMed Web of Science ®Google Scholar
• Deng H, Tanojo H, Lenn J. Foam as a novel vehicle in topical therapy. J. Am. Acad. Dermatol.50(Suppl. 3) P80 (2004).
   Web of Science ®Google Scholar
• Huang X, Tanojo H, Lenn J, Deng H, Krochmal L. A novel foam vehicle for delivery of topical corticosteroids. J. Am. Acad. Dermatol.53(1 Suppl. 1), S26–S38 (2005).
   PubMed Web of Science ®Google Scholar
• Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrheic dermatitis to ketoconazole. Br. J. Dermatol.111(5), 603–607 (1984).
   PubMed Web of Science ®Google Scholar
• Skinner RB, Rosenberg EW. Double-blind treatment of seborrheic dermatitis with ketoconazole cream. J. Am. Acad. Dermatol.12(5 Pt. 1), 852–856 (1985).
   PubMed Web of Science ®Google Scholar
• Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazole: response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br. J. Dermatol.116(2), 213–216 (1981)
   Google Scholar
• Pierard GE, Pierard-Franchimont C, Van Custem J, Rurangirwa A, Hoppenbrowers ML, Schroolen P. Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int. J. Dermatol.30(11), 806–809 (1991).
   PubMed Web of Science ®Google Scholar
• Pierard-Franchimont C, Pierard GE. A double blind, placebo-controlled study of ketoconazole plus desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology204(4), 344–347 (2002).
   PubMed Web of Science ®Google Scholar
• Elewski B, Ling MR, Phillips TJ. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a Phase III trial. J. Drugs Dermatol.5(7), 646–650 (2006).
   PubMedGoogle Scholar
• Elewski BE, Abramovits W, Kempers S et al. A novel foam formulation of ketoconazole, 2%, in the treatment of seborrheic dermatitis on all areas of the body. J. Drugs Dermatol., 6(10), 1001–1008 (2007).
   PubMedGoogle Scholar
• Koller T, Spellman M, Yaroshinsky A, Elewski BE. A randomized, double-blind, double-dummy, placebo-controlled study of the safety and efficacy of ketoconazole foam 2% versus ketoconazole 2% cream in the treatment of seborrheic dermatitis. J. Am. Acad. Dermatol.50(3 Suppl. 1), P103 (2004)
   Google Scholar